Albert D'heurle, MD
Orthopaedic Surgery · Lakewood, WANPI 1255775219
Payments from drug & device makers
Across 78 payments — averaging $223.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Stryker$3K
- Zimmer Biomet$3K
- Medacta USA, Inc.$371
- Medtronic$300
- Ferring Pharmaceuticals Inc.$100
- plus $575 from 16 others
What the payments were for
- Travel & lodging$4,45426%
- Food & beverage$2,95217%
- Education$10,00057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $10,031 |
| Stryker | 20 | $3,477 |
| Zimmer Biomet | 17 | $2,551 |
| Medacta USA, Inc. | 3 | $371 |
| Medtronic | 4 | $300 |
| Ferring Pharmaceuticals Inc. | 5 | $100 |
| DJO, LLC | 2 | $74 |
| Avanos Medical | 4 | $71 |
| Amgen | 3 | $70 |
| Johnson & Johnson(2 entities) | 3 | $54 |
| Fidia Pharma USA Inc. | 2 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Bioventus LLC | 1 | $30 |
| Pfizer | 1 | $27 |
| Baxter Healthcare | 1 | $24 |
| Orthofix Medical, Inc. | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Linvatec Corporation | 1 | $23 |
| Vertex | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,406 in reported general payments places this provider in the 80th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 182 | $1,063 |
| Cefazolin Sodium | 11 | $311 |
| Meloxicam | 68 | $277 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $233 |
| Hydromorphone Hcl | 31 | $149 |
| Cefadroxil | 14 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $112 |
| Ondansetron OdtOndansetron | 15 | $97 |
| Tramadol Hcl | 31 | $72 |
| Cyclobenzaprine Hcl | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lakewood
- William BarrettRenton$8.2M
- James PritchettSeattle$6.4M
- Jeffrey RohSeattle$4.7M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.8M
- Burt YaszaySeattle$1.5M
- Sean ToomeySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.